Eli Lilly CEO David Ricks speaks at the Economic Club of New York. (Photo by Spencer Platt/Getty Images)

Eli Lil­ly taps Ama­zon Phar­ma­cy to dis­pense its pre­scrip­tion med­i­cines

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.

Eli Lil­ly has struck a deal with Ama­zon Phar­ma­cy to de­liv­er its obe­si­ty, di­a­betes and mi­graine med­i­cines di­rect­ly to pa­tients. Ama­zon will work through Lil­ly’s re­cent­ly launched Lil­ly­Di­rect tele­health plat­form.

It’s the first time Ama­zon’s phar­ma­cy busi­ness has worked di­rect­ly with a drug­mak­er, es­tab­lish­ing a new kind of di­rect re­la­tion­ship be­tween the mak­er of a med­ica­tion and the tech and re­tail gi­ant. The new re­la­tion­ship dif­fers from how med­ica­tions are tra­di­tion­al­ly pre­scribed and then dis­pensed through a re­tail phar­ma­cy, po­ten­tial­ly dis­rupt­ing el­e­ments of those busi­ness­es and cre­at­ing a big busi­ness for Ama­zon Phar­ma­cy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.